Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 1 cze 2023 · This study presents a systematic literature review (SLR) of current clinical practice guidelines for screening, diagnosis, monitoring and treatment recommendations for the AD continuum with a focus on identifying key areas for future advancements.

  2. 13 mar 2018 · The overall purpose of this research is to determine if there is a relationship between symptoms of Dementia of the Alzheimers type and changes in the size and shape of certain brain structures during combined Donepezil (Aricept ®) and MEM (Namenda ®) treatment.

  3. 10 wrz 2020 · All four treatment regimens were well tolerated by most patients. Memantine was the best‐tolerated medication, followed by placebo and the combination of memantine plus donepezil. Donepezil was the least tolerable.

  4. 6 cze 2023 · Further pharmacological effects of memantine have been revealed and applied for clinical applications, such as neuroprotection in ischemic brain injury after cardiac arrest, treatment of vascular dementia, treatment of ischemic stroke, treatment of Parkinson's disease dementia, alleviation of acute lung injury (ALI), and so on.

  5. Memantine (MEM), an antagonist of extrasynaptic NMDAR, is currently used for the treatment of AD jointly with acetylcholinesterase inhibitors.

  6. 28 maj 2024 · Cholinesterase inhibitors and memantine are the only currently available symptomatic medications for cognition and global functioning in patients with dementia. Cholinesterase inhibitors target the acetylcholine deficit arising from loss of neurons in the nucleus basalis of Meynert and its projections in patients with dementia.

  7. o Memantine, 5-20mg/day, may be beneficial, if not already prescribed. o Trazodone 50 -150mg daily as a single or divided dose may help restlessness and agitation. o SSRIs, e.g. low dose sertraline, and mirtazapine 15-30mg/day, may be useful in obvious depressive symptoms.

  1. Ludzie szukają również